Bacteriophage therapy in implant-related infections: An experimental study

Journal of Bone and Joint Surgery

Volumn 95, Issue 2, 2013, Pages 117-125

  Yilmaz, Cengiz ^a   Colak, Mehmet ^a   Yilmaz, Banu Coskun ^a   Ersoz, Gulden ^a   Kutateladze, Mzia ^b   Gozlugol, Mehmet ^a  

^a MERSIN UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b George Eliava Institute of Bacteriophage Microbiology and Virology   (Georgia)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; C REACTIVE PROTEIN; CISPLATIN; IMIPENEM; PROBIOTIC AGENT; TEICOPLANIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIOPHAGE; BIOFILM; CONTROLLED STUDY; DEVICE INFECTION; ELECTRON MICROSCOPY; IMPLANT; LEUKOCYTE COUNT; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MICROSCOPY; NONHUMAN; OSTEOMYELITIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; RAT; STAPHYLOCOCCUS AUREUS;

EID: 84873675670     PISSN: 00219355     EISSN: 15351386     Source Type: Journal    
DOI: 10.2106/JBJS.K.01135     Document Type: Article

References (34)

1. Levy SB, Marshall B. Antibacterial resistance worldwide: causes, challenges and responses. Nat Med. 2004 Dec;10(12 Suppl):S122-9.
2. Deshpande LM, Jones RN, Fritsche TR, Sader HS. Occurrence and characterization of carbapenemase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program (2000-2004). Microb Drug Resist. 2006 Winter;12(4): 223-30.
3. Hanlon GW, Denyer SP, Olliff CJ, Ibrahim LJ. Reduction in exopolysaccharide viscosity as an aid to bacteriophage penetration through Pseudomonas aeruginosa biofilms. Appl Environ Microbiol. 2001 Jun;67(6):2746-53.
4. Doolittle MM, Cooney JJ, Caldwell DE. Tracing the interaction of bacteriophage with bacterial biofilms using fluorescent and chromogenic probes. J Ind Microbiol. 1996 Jun;16(6):331-41.
5. Donlan RM. Preventing biofilms of clinically relevant organisms using bacteriophage. Trends Microbiol. 2009 Feb;17(2):66-72. Epub 2009 Jan 21.
6. Albee FH. The treatment of osteomyelitis by bacteriophage. J Bone Joint Surg Am. 1933;15:58-66.
7. Twort F. An investigation on the nature of ultra-microscopic viruses. Lancet. 1915;2:1241-3.
8. D'Herelle F. Sur un microbe invisible antagoniste des bacilles dysenteriques. C.R. Acad Sci Paris. 1917;165:373-5.
9. Alisky J, Iczkowski K, Rapoport A, Troitsky N. Bacteriophages show promise as antimicrobial agents. J Infect. 1998 Jan;36(1):5-15.
10. Matsuzaki S, Yasuda M, Nishikawa H, Kuroda M, Ujihara T, Shuin T, Shen Y, Jin Z, Fujimoto S, Nasimuzzaman MD, Wakiguchi H, Sugihara S, Sugiura T, Koda S, Muraoka A, Imai S. Experimental protection of mice against lethal Staphylococcus aureus infection by novel bacteriophage phi MR11. J Infect Dis. 2003 Feb 15; 187(4):613-24. Epub 2003 Feb 7.
11. O'Flaherty S, Ross RP, Meaney W, Fitzgerald GF, Elbreki MF, Coffey A. Potential of the polyvalent anti-Staphylococcus bacteriophage K for control of antibiotic-resistant staphylococci from hospitals. Appl Environ Microbiol. 2005 Apr;71(4):1836-42.
12. Young R. Bacteriophage lysis: mechanism and regulation. Microbiol Rev. 1992 Sep;56(3):430-81.
13. Wang IN, Smith DL, Young R. Holins: the protein clocks of bacteriophage infections. Annu Rev Microbiol. 2000;54:799-825.
14. Capparelli R, Parlato M, Borriello G, Salvatore P, Iannelli D. Experimental phage therapy against Staphylococcus aureus in mice. Antimicrob Agents Chemother. 2007 Aug;51(8):2765-73. Epub 2007 May 21.
15. Soothill JS. Treatment of experimental infections of mice with bacteriophages. J Med Microbiol. 1992 Oct;37(4):258-61.
16. Kvachadze L, Balarjishvili N, Meskhi T, Tevdoradze E, Skhirtladze N, Pataridze T, Adamia R, Topuria T, Kutter E, Rohde C, Kutateladze M. Evaluation of lytic activity of staphylococcal bacteriophage Sb-1 against freshly isolated clinical pathogens. Microb Biotechnol. 2011 Sep;4(5):643-50. doi: 10.1111/j.1751-7915.2011.00259.x. Epub 2011 Apr 11.
17. Gabrilovich IM. Basics of bacteriophage research. Minsk: Visheishaya Shkola; 1973.
18. Ersoz G, Oztuna V, Coskun B, Eskandari MM, Bayarslan C, Kaya A. Addition of fusidic acid impregnated bone cement to systemic teicoplanin therapy in the treatment of rat osteomyelitis. J Chemother. 2004 Feb;16(1):51-5.
19. Calikoglu M, Tamer L, Sucu N, Coskun B, Ercan B, Gul A, Calikoglu I, Kanik A. The effects of caffeic acid phenethyl ester on tissue damage in lung after hindlimb ischemia-reperfusion. Pharmacol Res. 2003 Oct;48(4):397-403.
20. Aytacoglu BN, Calikoglu M, Tamer L, Cosxkun B, Sucu N, Köse N, Aktas S, Dikmengil M. Alcohol-induced lung damage and increased oxidative stress. Respiration. 2006;73(1):100-4. Epub 2005 Sep 29.
21. Woods AE, Stirling JW. Electron microscopy. In: Bancroft JD, Gamble M, editors. Theory and practice of histological techniques. 6th ed. Philadelphia: Churchill Livingstone, Elsevier; 2008. p 601-40.
22. Karthikeyan S, Beveridge TJ. Pseudomonas aeruginosa biofilms react with and precipitate toxic soluble gold. Environ Microbiol. 2002 Nov;4(11):667-75.
23. Sass P, Bierbaum G. Lytic activity of recombinant bacteriophage phi11 and phi12 endolysins on whole cells and biofilms of Staphylococcus aureus. Appl Environ Microbiol. 2007 Jan;73(1):347-52. Epub 2006 Nov 3.
24. Gracia E, Laclériga A, Monzón M, Leiva J, Oteiza C, Amorena B. Application of a rat osteomyelitis model to compare in vivo and in vitro the antibiotic efficacy against bacteria with high capacity to form biofilms. J Surg Res. 1998 Oct;79(2):146-53.
25. Monzón M, Garciá-Alvarez F, Laclériga A, Gracia E, Leiva J, Oteiza C, Amorena B. A simple infection model using pre-colonized implants to reproduce rat chronic Staphylococcus aureus osteomyelitis and study antibiotic treatment. J Orthop Res. 2001 Sep;19(5):820-6.
26. Kutateladze M, Adamia R. Bacteriophages as potential new therapeutics to replace or supplement antibiotics. Trends Biotechnol. 2010 Dec;28(12):591-5. Epub 2010 Aug 31.
27. Kutateladze M, Adamia R. Phage therapy experience at the Eliava Institute. Med Mal Infect. 2008 Aug;38(8):426-30. Epub 2008 Aug 6.
28. Wills QF, Kerrigan C, Soothill JS. Experimental bacteriophage protection against Staphylococcus aureus abscesses in a rabbit model. Antimicrob Agents Chemother. 2005 Mar;49(3):1220-1.
29. Samsygina GA, Boni EG. [Bacteriophages and phage therapy in pediatric practice]. Pediatriia. 1984 Apr;(4):67-70. Russian.
30. Tolkacheva TV, Abakumov EM, Martynova VA, Golosova TV. [Correction of intestinal dysbacteriosis with biological preparations in acute leukemia]. Probl Gematol Pereliv Krovi. 1981 Jul;26(7):29-33. Russian.
31. Rashel M, Uchiyama J, Ujihara T, Uehara Y, Kuramoto S, Sugihara S, Yagyu K, Muraoka A, Sugai M, Hiramatsu K, Honke K, Matsuzaki S. Efficient elimination of multidrug-resistant Staphylococcus aureus by cloned lysin derived from bacteriophage phi MR11. J Infect Dis. 2007 Oct 15;196(8):1237-47. Epub 2007 Sep 11.
32. Kvachadze L, Balarjishvili N, Meskhi T, Tevdoradze E, Skhirtladze N, Pataridze T, Adamia R, Topuria T, Kutter E, Rohde C, Kutateladze M. Evaluation of lytic activity of staphylococcal bacteriophage Sb-1 against freshly isolated clinical pathogens. Microb Biotechnol. 2011 Sep;4(5):643-50. doi: 10.1111/j.1751-7915.2011.00259.x. Epub 2011 Apr 11.
33. Lang G, Kehr P, Mathevon H, Clavert JM, Séjourne P, Pointu J. [Bacteriophage therapy of septic complications of orthopaedic surgery (author's transl]. Rev Chir Orthop Reparatrice Appar Mot. 1979 Jan-Feb;65(1):33-7. French.
34. Miedzybrodzki R, Fortuna W, Weber-Dabrowska B, Górski A. A retrospective analysis of changes in inflammatory markers in patients treated with bacterial viruses. Clin Exp Med. 2009 Dec;9(4):303-12. Epub 2009 Apr 7.